{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:07:45Z","timestamp":1788959265329,"version":"build-2803163510"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pediatric dyslipidemia is common worldwide, especially in Lebanon, and is associated with increased long-term cardiovascular risk. However, international screening recommendations are still controversial. In Lebanon, no study has assessed physicians\u2019 knowledge, attitudes, and practices (KAPs) about this screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional online questionnaire-based study was conducted among pediatricians, family medicine physicians, and endocrinologists practicing in Lebanon. The questionnaire assessed knowledge, attitudes, screening practices, and perceived barriers regarding pediatric dyslipidemia. Associations between variables were examined using univariate and multivariable analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 245 physicians participated in the study. Performance on the nine selected knowledge items was low (mean score of 53.2 \u00b1 22.1 out of 100, median 55.6), with gaps mainly related to the prevalence of pediatric dyslipidemia in Lebanon and familiarity with international recommendations. Attitudes toward screening were generally favorable (mean score of 77.8 \u00b1 14.2 out of 100, median 80), although 56.3% of participants reported concerns about family anxiety. Screening practices were heterogeneous and primarily relied on targeted screening when risk factors were present. Screening in adolescents was performed (always or most of the time) by 40.3% of endocrinologists, 32.6% of family medicine physicians, and 19.3% of pediatricians, with laboratory test costs and parental consent being the main obstacles (49.8% and 33.9%, respectively). The score based on the nine selected knowledge items showed a weak positive correlation with the attitude score (Spearman\u2019s \u03c1 = 0.135, p = 0.035). Attitude scores differed significantly across reported screening-frequency categories (p&amp;lt;0.001). In multivariable analysis, female sex, family medicine practice, and practice in Beirut\/Mount Lebanon (BML) were independently associated with higher score on the nine selected knowledge items (p=0.015, p&amp;lt;0.001, and p=0.005, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite favorable attitudes, insufficient knowledge and contextual barriers limit the systematic implementation of pediatric dyslipidemia screening in Lebanon. Actions that combine training, harmonization of recommendations, and improved access to screening could strengthen pediatric cardiovascular prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1900463","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:34:26Z","timestamp":1788957266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge, attitudes, and practices of Lebanese physicians on the screening of pediatric dyslipidemias: a KAP cross-sectional study"],"prefix":"10.3389","volume":"17","author":[{"given":"Marie-H\u00e9l\u00e8ne","family":"Gannag\u00e9-Yared","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France hospital, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy El","family":"Habre","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France hospital, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bachir","family":"Atallah","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bou Absi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France hospital, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada El","family":"Ghorayeb","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France hospital, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maissa","family":"Safieddine","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Faculty of Medicine, Saint-Joseph University","place":["Beirut, Lebanon"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15620\/cdc:122516","article-title":"Mortality in the United States, 2021","author":"Xu","year":"2022","journal-title":"NCHS Data Brief"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109191","article-title":"Childhood cardiovascular risk factors and adult cardiovascular events","volume":"386","author":"Jacobs","year":"2022","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.03.529","article-title":"Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events","volume":"74","author":"Zhang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12944-024-02336-1","article-title":"Prevalence of and factors associated with lipid screening in young people aged 16- to 21 years in the United States: analysis of nationwide cross-sectional data","volume":"23","author":"Li","year":"2024","journal-title":"Lipids Health Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.12.018","article-title":"Distribution and correlates of non-high-density lipoprotein cholesterol and triglycerides in Lebanese school children","volume":"10","author":"Gannag\u00e9-Yared","year":"2016","journal-title":"J Clin Lipidol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpam.2019.05.003","article-title":"Universal screening program for lipid disorders in 2-10 years old Lebanese children: A new approach","volume":"6","author":"Georges","year":"2019","journal-title":"Int J Pediatr Adolesc Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","year":"2011","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11330","article-title":"Screening for lipid disorders in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"330","author":"Barry","year":"2023","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-021-02767-y","article-title":"Practices and attitudes regarding pediatric cholesterol screening recommendations differ between pediatricians and family medicine clinicians","volume":"43","author":"Zhang","year":"2022","journal-title":"Pediatr Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04572-2","article-title":"Current guidelines on screening, diagnosis and management of dyslipidaemia in childhood: a systematic review","volume":"99","author":"Patro-Golab","year":"2025","journal-title":"Pediatr Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216479","article-title":"Screening and management of dyslipidemia in children and adolescents","volume":"11","author":"Schefelker","year":"2022","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.2410","article-title":"Cholesterol testing among children and adolescents during health visits","volume":"311","author":"Vinci","year":"2014","journal-title":"JAMA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.000842","article-title":"Lipid screening in children and adolescents in community practice: 2007 to 2010","volume":"7","author":"Margolis","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2015.06.014","article-title":"Temporal trends in lipid screening and therapy among youth from 2002 to 2012","volume":"9","author":"Zachariah","year":"2015","journal-title":"J Clin Lipidol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-025-03831-7","article-title":"Changes in youth cholesterol screening rates in an academic center during the COVID-19 pandemic","volume":"47","author":"Schwartz","year":"2026","journal-title":"Pediatr Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpeds.2016.12.078","article-title":"Cholesterol screening and treatment practices and preferences: a survey of United States pediatricians","volume":"185","author":"de Ferranti","year":"2017","journal-title":"J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpeds.2017.05.030","article-title":"Improving universal pediatric lipid screening","volume":"188","author":"DeSantes","year":"2017","journal-title":"J Pediatr"},{"key":"B19","unstructured":"The KAP Survey Model (Knowledge, Attitudes, and Practices) | SPRING\n          \n          \n          2025"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/life11040345","article-title":"Early prevention of atherosclerosis: detection and management of hypercholesterolaemia in children and adolescents","volume":"11","author":"Pederiva","year":"2021","journal-title":"Life"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.10.027","article-title":"Implementation of lipid screening guidelines in children by primary pediatric providers","volume":"164","author":"Dixon","year":"2014","journal-title":"J Pediatr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.05.035","article-title":"Pediatric lipid screening and treatment in Canada: practices, attitudes, and barriers","volume":"36","author":"Khoury","year":"2020","journal-title":"Can J Cardiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21724","article-title":"Pediatric lipid screening prevalence using nationwide electronic medical records","volume":"7","author":"Thompson-Paul","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/00099228221075409","article-title":"Universal lipid screening among 9- to 11-year-old children: screening results and physician management","volume":"61","author":"Eichberger","year":"2022","journal-title":"Clin Pediatr (Phila)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2024.01.001","article-title":"Using implementation science to develop a familial hypercholesterolemia screening program in primary care: the CARE-FH study","volume":"18","author":"Jones","year":"2024","journal-title":"J Clin Lipidol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-026-28254-8","article-title":"Dyslipidemia in Lebanese children and adolescents: parents\u2019 knowledge and practices","author":"Bou Hamdan","year":"2026","journal-title":"BMC Public Health"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1900463\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:34:27Z","timestamp":1788957267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1900463\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":27,"alternative-id":["10.3389\/fendo.2026.1900463"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1900463","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"article-number":"1900463"}}